Total Market Initiative

Hondurasfrom Engagement to Action

Pamela Riley, Abt Associates, SHOPSRHSC Annual Meeting

May 28, 2010 Kampala, Uganda

Contents

Background TMI Honduras

Why Honduras?Key success

factorsWorkshop videoLessons learnedNext steps

Background of TMI

Grant from RHSC Innovation Fund 2009 JSI and Abt Associates implementers

Key objectives Alignment with existing contraceptive security strategy Consolidate information on market to guide process Expand participation in the FP market Facilitate greater stakeholder collaboration

Political challenges June 2009 coup d’etat

Why Honduras?

Graduating from international FP aid

Resource gaps

Existing CS Committee (DAIA)

Active private sector

Strong DHS And. . .

Flat CPR growth with rising unmet need

16%

11%

Ch

ang

e (%

)

Unmet Need

65.2%

62%

2001 2005

Ch

an

ge

(%

)

CPR

TMI Key success factor: local leadership

Initial CS Committee (DAIA) in April 2009 Approved detailed plans and milestones Deep involvement in planning data analyses

to be conducted Generated broad list of stakeholders for

outreach, open to inclusion of new players Pre-workshop DAIA session February

2010 approved agenda and roles

TMI key success factor: market analysis Conducted in several stages

Quantitative research: secondary market analysis utilizing DHS

Qualitative research: Focus groups to uncover motivations and attitudes

Supply analysis: using IMS data for hormonals, NGO data for condom markets

Stakeholder interviews Shed light on inefficiencies, gaps and missed

opportunities

Sample segment analyses: women in union

Segment 1: “Young women in union:

15-25 years old, average children 2.1

Users: 53% modern methods

Future intent: Injectables preferred

Non-users:

98% want more children

Segment 3: “Thirty-somethings”

30-39 years old, average children 4.1

Users: 62% modern methods

Future intent: Sterilization preferred

Non-users:

Unmet need higher in rural areas

Segment 2: “I think my family is complete.”15-29 years old, average children 2.8

Users: 67% modern methods

Future intent: Injectables preferred

Non-users:

Majority want no more children

Segment 4: “Menopausal”

40-49 years old, average children 5.6

Users: 45% modern methods

Future intent: low percent

Non-users: Do not want more children

Sample data analyses: FP users in lower quintiles not in urban areas

Distribution of Population by Wealth Quintile

0%

10%

20%

30%

40%

50%

1 2 3 4 5

Wealth Quintile

Rural

Urbana

Key success factor: courting new participants

PUBLIC SECTORMinistry of Health

Social Security Institute

Technical Advisory Unit MOH

Institute Public Health

National Drug Regulatory Authority

National Institute for Statistics

PRIVATE FOR-PROFIT

Medical Center of San Miguel

Pfizer

Durex Distributor Solis

CPL Condom Manufacturer

Vijosa Injectables Manufacturer

Arsal Laboratories

NGOsIPPF Affiliate Ashonplafa

Association of Women and Families

College of Pharmacists

National Medical University

PSI Affiliate PASMO

National Association for Ob-Gynocologists

National Organization for Women

INTERNATIONAL AGENCIESKfW

Global Fund

UNFPA

USAID

Workshop Video

Lessons Learned

Country-led, country-owned

Stakeholders must be treated as equals in the process

There is demand for capacity building in data analysis

The commercial sector can be a willing partner in CS

From strategies to action plans

TMI results: a re-invigorated process and expanded stakeholder community

Current DAIA activities in development Multi-sector BCC campaigns Creation of FP website to institutionalize

information access Detailed mapping of FP stakeholders Institutional pricing for public sector sales Public sector commitment to target rural areas

Thank you from TMI Honduras